兴齐眼药股价涨5.05%，国联安基金旗下1只基金重仓，持有1.68万股浮盈赚取6.05万元

Group 1 - The core point of the news is the significant increase in the stock price of Xingqi Eye Pharmaceutical, which rose by 5.05% to 74.95 CNY per share, with a trading volume of 983 million CNY and a turnover rate of 7.24%, leading to a total market capitalization of 18.389 billion CNY [1] - Xingqi Eye Pharmaceutical, established on March 24, 1977, and listed on December 8, 2016, specializes in the research, production, and sales of ophthalmic drugs, with its main business revenue composition being 82.15% from eye drops, 16.70% from gel/eye ointments, and 1.15% from other supplementary products [1] Group 2 - From the perspective of fund holdings, Guolian An Fund has a significant position in Xingqi Eye Pharmaceutical, with its Guolian An New Selected Mixed A Fund (000417) increasing its holdings by 1,800 shares in the second quarter, totaling 16,800 shares, which represents 2.58% of the fund's net value, making it the sixth-largest holding [2] - The Guolian An New Selected Mixed A Fund, established on March 4, 2014, has a latest scale of 33.7121 million CNY, with a year-to-date return of 8.1% and a one-year return of 9.58%, ranking 5,947 out of 8,095 in its category [2] - The fund manager, Zhang Zhenyuan, has been in the position for 11 years and 323 days, managing total assets of 40.811 billion CNY, with the best fund return during his tenure being 387.76% and the worst being -35.8% [2]